| Structure |
Chemical Name |
CAS |
MF |
 |
4,4'-(1,3-プロパンジイル)ビスモルホリン |
48152-09-6 |
C11H22N2O2 |
 |
Remifentanil Impurity 1 (RTF-02) |
938184-94-2 |
C16H21N3O2 |
 |
4-フェニル-1-(フェニルメチル)-4-ピペリジノール |
63843-83-4 |
C18H21NO |
 |
rac-(R*)-4-アミノ-N,N,N-トリメチル-2-ヒドロキシ-4-オキソブタン-1-アミニウム·クロリド |
5261-99-4 |
C7H18ClN2O2+ |
![methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](/CAS/20200611/GIF/383910-25-6.gif) |
methyl (3aS,4R,6S,6aR)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |
383910-25-6 |
C18H30N2O5 |
 |
17,21-ジヒドロキシ-16β-メチルプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
13504-15-9 |
C22H28O4 |
![Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2300968-87-8.gif) |
Sulfamide, N-[6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-5-phenyl-4-pyrimidinyl]-N'-propyl- |
2300968-87-8 |
C19H21BrN6O4S |
 |
sodium (((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy) methyl)oxidophosphoryl)-L-alaninate |
382140-24-1 |
C12H19N6O5P |
 |
Benzeneacetonitrile, 4-(4-chloro-1-oxobutyl)-α,α-dimethyl- |
169032-17-1 |
C14H16ClNO |
 |
Zopiclone Impurity 13 |
|
|
|
|
Oseltamivir Impurity 103 |
|
|
 |
1-メチルインドリン-2,3-ジオン |
2058-74-4 |
C9H7NO2 |
|
|
Oseltamivir Impurity 101 |
|
|
|
|
Oseltamivir Impurity 90 |
|
|
 |
1-bromo-3-(4-ethoxybenzyl)benzene |
898538-17-5 |
C15H15BrO |
|
|
Oseltamivir Impurity 79 |
|
|
 |
(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)(methoxy) methyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
1318794-28-3 |
C22H27ClO7 |
|
|
Oseltamivir Impurity 73 |
|
|
|
|
Oseltamivir Impurity 69 |
|
|
 |
10-メトキシ-6-メチルエルゴリン-8β-メタノール |
35121-60-9 |
C17H22N2O2 |
 |
Azilsartan medoxomil impurity261 |
2514957-39-0 |
C16H16FN3O4 |
![Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester](/CAS/20210305/GIF/127373-95-9.gif) |
Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(2-methoxy-2-oxoethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester |
127373-95-9 |
C21H24N2O7S |
|
|
Fulvestrant Impurity 1 |
|
|
|
|
CefazolinH020-02-I-02 |
|
|
![2-[(E)-シアノ(2,3-ジクロロフェニル)メチレン]ヒドラジンカルボイミドアミド](/CAS/GIF/94213-24-8.gif) |
2-[(E)-シアノ(2,3-ジクロロフェニル)メチレン]ヒドラジンカルボイミドアミド |
94213-24-8 |
C9H7Cl2N5 |
![5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]-](/CAS/20210305/GIF/2606144-44-7.gif) |
5-Pyrimidinecarboxylic acid, 4-amino-6-[1-[(1R)-2-cyano-1-cyclopentylethyl]-1H-pyrazol-4-yl]- |
2606144-44-7 |
C16H18N6O2 |
![3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-](/CAS/20210305/GIF/1395471-26-7.gif) |
3-Quinolinecarboxylic acid, 7-[(4aS,7aS)-1-acetyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-4-oxo- |
1395471-26-7 |
C23H26FN3O5 |
![N-[3-アセチル-4-(オキシラニルメトキシ)フェニル]ブタンアミド](/CAS/GIF/28197-66-2.gif) |
N-[3-アセチル-4-(オキシラニルメトキシ)フェニル]ブタンアミド |
28197-66-2 |
C15H19NO4 |
![8-イソプロピル-8-アザビシクロ[3.2.1]オクタン-3-オン](/CAS/GIF/3423-28-7.gif) |
8-イソプロピル-8-アザビシクロ[3.2.1]オクタン-3-オン |
3423-28-7 |
C10H17NO |
|
|
Sitagliptin EP Impurity 4 |
|
|
![1-[3,5-ビス(フェニルメトキシ)フェニル]-2-ブロモエタノン](/CAS/GIF/28924-18-7.gif) |
1-[3,5-ビス(フェニルメトキシ)フェニル]-2-ブロモエタノン |
28924-18-7 |
C22H19BrO3 |
![Benzenesulfonic acid, 4-[2-(2-chloro-4-hydroxyphenyl)hydrazinyl]-](/CAS/20210305/GIF/2174956-62-6.gif) |
Benzenesulfonic acid, 4-[2-(2-chloro-4-hydroxyphenyl)hydrazinyl]- |
2174956-62-6 |
C12H11ClN2O4S |
|
|
4,4',6-trioxo-4,4',5,6,7,7'-hexahydro-1H,1'H-[5,6'-bipyrrolo[2,3-d]pyrimidine]-5,5'-diyl)bis(ethane-2,1-diyl))bis(benzoyl))bis(azanediyl))dipentanedioic acid |
|
|
|
|
Cefotiam impurity 07 |
|
|
 |
1,3-ベンゾジオキソール-5-オールアセタート |
326-58-9 |
C9H8O4 |
![2,4-ジアミノ[スルホニルビスベンゼン]](/CAS/GIF/27147-69-9.gif) |
2,4-ジアミノ[スルホニルビスベンゼン] |
27147-69-9 |
C12H12N2O2S |
 |
p-トリルグリシジルエーテル |
2186-24-5 |
C10H12O2 |
 |
3-ヒドロキシアゾベンゼン |
2437-11-8 |
C12H10N2O |
![7-CHLORO-1-ETHYL-6-FLUORO-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID](/CAS/GIF/79286-73-0.gif) |
7-CHLORO-1-ETHYL-6-FLUORO-4-OXO-1,4-DIHYDRO-[1,8]NAPHTHYRIDINE-3-CARBOXYLIC ACID |
79286-73-0 |
C11H8ClFN2O3 |
 |
HYDRIDE-L |
41639-74-1 |
C18H22O4 |
 |
2-Amino-4-trifluoromethoxybenzothiazole |
235101-36-7 |
C8H5F3N2OS |
![7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプタン-5-イル]-8-クロロ-6-フルオロ-1-[(1R,2S)-2-フルオロシクロプロピル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸](/CAS2/GIF/127254-10-8.gif) |
7-[(7R)-7-アミノ-5-アザスピロ[2.4]ヘプタン-5-イル]-8-クロロ-6-フルオロ-1-[(1R,2S)-2-フルオロシクロプロピル]-4-オキソ-1,4-ジヒドロキノリン-3-カルボン酸 |
127254-10-8 |
C19H18ClF2N3O3 |
 |
Sitagliptin Carbamoyl -D-Glucuronide |
940002-59-5 |
C23H23F6N5O9 |
 |
5-Hydroxy Desloratadine |
117811-12-8 |
C19H19ClN2O |
 |
O-Benzyl Posaconazole |
170985-86-1 |
C44H48F2N8O4 |
 |
(4-Carboxy-3-ethoxy)phenyl Acetic Acid (Repaglinide Impurity) |
220438-80-2 |
C11H12O5 |
 |
2-クロロメチル-3,5-ジメチルピリジン-4-オール |
220771-03-9 |
C8H10ClNO |
![2-Methyl-6-[(4-methylphenyl)sulfonyl]-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine](/CAS2/GIF/717917-14-1.gif) |
2-Methyl-6-[(4-methylphenyl)sulfonyl]-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepine |
717917-14-1 |
C19H19N3O2S |
 |
Brivaracetam Impurity |
2432911-37-8 |
C11H22O3 |
|
|
Cefminox Sodium impurity 5 |
|
|
 |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
 |
Nimodipine Impurity 12 |
39562-18-0 |
C19H22N2O6 |
|
|
Rosuvastatin Impurity 53 |
|
|
 |
Sulbactam Impurity 8 |
75527-88-7 |
C8H10BrNO5S |
![(1R-4S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid methyl ester](/CAS2/GIF/251326-99-5.gif) |
(1R-4S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]- 2-Cyclopentene-1-carboxylic acid methyl ester |
251326-99-5 |
C12H19NO4 |
 |
O-イソブチリル(R)-フェソテロジン |
1208313-13-6 |
C30H43NO4 |
 |
Isopropyl Itraconazole |
89848-49-7 |
C34H36Cl2N8O4 |
 |
(R)-(-)-イブプロフェン-D3 |
121702-86-1 |
C13H18O2 |
 |
(S,R,S,S)-Orlistat |
111466-63-8 |
C29H53NO5 |
 |
N-Trityl Candesartan Ethyl Ester |
856414-35-2 |
C45H38N6O3 |
![3R,4S-4-(4-methoxyphenyl)-1-methylpiperi
dinyl] methanol](/CAS/20200611/GIF/127017-78-1.gif) |
3R,4S-4-(4-methoxyphenyl)-1-methylpiperi
dinyl] methanol |
127017-78-1 |
C14H21NO2 |
 |
ENT-エンテカビル |
188399-46-4 |
C12H15N5O3 |
 |
Valsartan cyano analog methyl ester |
137863-90-2 |
C25H30N2O3 |
 |
(8S)-2-BroMo α-Ergocryptine |
65700-36-9 |
C32H40BrN5O5 |
![3-[4-(4-クロロベンゾイル)フェノキシ]-2-ブタノン(FENOFIBRATE IMPURITY)](/CAS/GIF/217636-47-0.gif) |
3-[4-(4-クロロベンゾイル)フェノキシ]-2-ブタノン(FENOFIBRATE IMPURITY) |
217636-47-0 |
C17H15ClO3 |
![5-(2-クロロベンジル)-チエノ[3,2-C]ピリジニウムクロリド](/CAS/GIF/53885-64-6.gif) |
5-(2-クロロベンジル)-チエノ[3,2-C]ピリジニウムクロリド |
53885-64-6 |
C14H11Cl2NS |
 |
ClarithroMycin 9-OxiMe |
103450-87-9 |
C38H70N2O13 |
 |
デスロラタジンN-ヒドロキシピペリジン |
1193725-73-3 |
C19H19ClN2O |
 |
O-DesMethyl Venlafaxine Cyclic IMpurity |
1346601-55-5 |
C16H23NO2 |
 |
rac-cis-2,3-Dichloro Sertraline Hydrochloride |
1198084-29-5 |
C17H17Cl2N.ClH |
 |
11β-Hydroperoxy Dienogest |
106111-43-7 |
C20H25NO4 |
 |
2'-Nor ThiaMine |
7770-93-6 |
C11H15ClN4OS |
 |
6α-メチルヒドロコルチソンアセタート |
1625-11-2 |
C24H34O6 |
 |
N1-Losartanyl-losartan (Losartan IMpurity) |
230971-71-8 |
C44H44Cl2N12O |
 |
N2-Losartanyl-losartan (Losartan IMpurity) |
230971-72-9 |
C44H44Cl2N12O |
 |
N-エトキシカルボニル7-ADCA |
72820-16-7 |
C11H14N2O5S |
 |
4-PyridinecarboxaMide, N-(2,6-diMethylphenyl)- |
68280-05-7 |
C14H14N2O |
 |
4-N-Desacetyl-5-N-acetyl OseltaMivir |
956267-10-0 |
C16H28N2O4 |
 |
rac N-DesMethyl-N-(4-Methoxyphenethyl) Venlafaxine |
1346601-14-6 |
C25H35NO3 |
 |
11-Keto Oxcarbazepine |
537693-29-1 |
C15H10N2O3 |
 |
4-(3-アミノフェニル)-1,4-ジヒドロ-5-(2-メトキシエトキシカルボニル)-2,6-ジメチルピリジン-3-カルボン酸イソプロピル |
155861-24-8 |
C21H28N2O5 |
 |
(E)-Olopatadine |
113806-06-7 |
C21H23NO3 |
 |
ネマジピンB |
79925-38-5 |
C19H21Cl2NO4 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole](/CAS/GIF/957470-59-6.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole |
957470-59-6 |
C24H24F2N4O6S |
 |
4-Epi-6-epi Doxycycline |
97583-08-9 |
C22H24N2O8 |
 |
Ethyl 3,4-O-Isopropylidene-5-O-methanesulfonylshikimate |
204254-84-2 |
C13H20O7S |
![2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris-](/CAS/20180808/GIF/390800-88-1.gif) |
2-PyrazinecarboxaMide, N,N',N''-[2,4,6-boroxintriyltris[[(1R)-3-Methylbutylidene]iMino[(1S)-2-oxo-1-(phenylMethyl)-2,1-ethanediyl]]]tris- |
390800-88-1 |
C57H69B3N12O9 |
![Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol)](/CAS/GIF/108928-81-0.gif) |
Salmeterol Related Compound B (10 mg) (4-{1-Hydroxy-2-[6-(4-phenylbutan-2-yloxy)hexylamino]ethyl}-2-(hydroxymethyl)phenol) |
108928-81-0 |
C25H37NO4 |
![3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン](/CAS/GIF/73278-98-5.gif) |
3-[3-(ピペリジノメチル)フェノキシ]-1-プロパンアミン |
73278-98-5 |
C15H24N2O |
 |
7,10-Bis-O-(2,2,2-trichloroethoxycarbonyl)-10-deacetylbaccatin III |
95603-44-4 |
C35H38Cl6O14 |
 |
4-(3-AMino-phenyl)-Morpholin-3-one |
1082495-22-4 |
C10H12N2O2 |
|
|
piperacillinylaMpicillin |
|
|
|
|
Celecoxib iMpurity-B |
|
|
|
|
EMtricitabine iMpurity B |
|
|
![(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone](/CAS/GIF/14842-41-2.gif) |
(S,S)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,6,8,12-tetrone |
14842-41-2 |
C10H10N2O4 |
 |
BroMhexine Hydrochloride iMpurity DN-(2-AMino-5-broMobenzyl)-N-MethylcyclohexanaMine Dihydrochloride |
132004-28-5 |
C14H21BrN2 |
 |
2-(DiMethylcarbaMoyl)benzoic acid, 97% |
20320-37-0 |
C10H11NO3 |
 |
RAC DESMETHYL CITALOPRAM HYDROCHLORIDE |
97743-99-2 |
C19H19FN2O |
 |
2-Demethoxy-4-methoxy urapidil |
34661-79-5 |
C20H29N5O3 |
 |
1-(5-O-アセチル-β-D-リボフラノシル)-1H-1,2,4-トリアゾール-3-カルボアミド |
58151-87-4 |
C10H14N4O6 |